Embark on Intermountain Healthcare's inspiring journey towards health equity! Discover how they're uniting the power of data with a commitment to culture change to create a fairer healthcare experience for all. From using clever dashboards to uncover disparities to fostering brave conversations about systemic racism, see how Intermountain is taking essential first steps, learning along the way, to build a future where everyone can live their healthiest life. It's a testament to progress, one thoughtful step at a time!

Dementia, a broad term for a decline in mental ability severe enough to interfere with daily life, is a growing global health concern. As populations age, understanding the true scope of dementia becomes crucial for healthcare planning

Discover the extensive applications of Artificial Intelligence (AI) in pharmaceutical and healthcare research. Learn how AI is used for drug discovery, disease diagnosis, including cancer and dementia, and personalized treatment. Explore AI's crucial role in clinical trials, aiding in design, patient selection, monitoring, and analysis, and its potential to uncover valuable insights hidden in clinical protocols. Find out how AI assists in forecasting epidemics and pandemics.

Learn how novel approaches to clinical trial design, including integrated models and adaptive methods, are addressing the high costs and inefficiency of traditional drug development, particularly in Phase II and III trials, to reduce attrition rates and increase productivity.

This research looks at how memory and thinking skills change in middle-aged Spanish people who don't have the brain changes usually seen in Alzheimer's disease. Scientists checked their brain fluid to confirm this. They used special methods to track these changes over time and created new ways to compare their scores that are more sensitive than regular tests. The results suggest these new methods might be slightly better at finding very early, subtle declines in memory, which could be a sign of preclinical Alzheimer's. This study hopes to provide doctors with another tool to help spot early changes that might lead to Alzheimer's later in life.

Acquire knowledge concerning Alzheimer's disease diagnosis, prevailing symptomatic treatments, and ongoing research initiatives dedicated to early intervention strategies and therapeutic approaches targeting amyloid and tau proteins.

Explore the critical topic of minority engagement in US clinical research on the Glassbury Cares Podcast. We discuss the persistent challenges of lower participation rates among racial and ethnic minorities in clinical trials, including HIV research. Understand how distrust of the medical community and research, significantly influenced by historical events like the Tuskegee study, acts as a barrier. Learn about other impediments, such as accessibility issues, time commitments, language barriers, stigma, and limited knowledge. Discover facilitators that encourage participation, including altruism, perceived personal and community benefits, trust, culturally relevant services, and monetary compensation. We examine ethical considerations, the importance of justice, and strategies like community-based participatory research to build trust and address structural barriers